Passa al contenuto
Merck
Tutte le immagini(2)

Documenti fondamentali

855775P

Avanti

18:0 Lyso PC

Avanti Research - A Croda Brand

Sinonimo/i:

1-octadecanoyl-sn-glycero-3-phosphocholine; PC(18:0/0:0)

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Formula empirica (notazione di Hill):
C26H54NO7P
Numero CAS:
Peso molecolare:
523.68
Codice UNSPSC:
51191904
NACRES:
NA.25

Descrizione

1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine

Saggio

>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)

Forma fisica

powder

Confezionamento

pkg of 1 × 1 g (855775P-1g)
pkg of 1 × 200 mg (855775P-200mg)
pkg of 1 × 25 mg (855775P-25mg)
pkg of 1 × 500 mg (855775P-500mg)

Produttore/marchio commerciale

Avanti Research - A Croda Brand

Condizioni di spedizione

dry ice

Temperatura di conservazione

−20°C

Stringa SMILE

O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COC(CCCCCCCCCCCCCCCCC)=O

InChI

1S/C26H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h25,28H,5-24H2,1-4H3
IHNKQIMGVNPMTC-UHFFFAOYSA-N

Applicazioni

18:0 Lyso PC has been used:
  • to functionalize carbon nanotubes (CNTs) for the development of methods to attach DNA to CNTs
  • to increase the level of lysophosphatidic acid (LPA) in mouse
  • to induce TNF receptor associated factor 3 interacting protein 2 (TRAF3IP2) expression in endothelial cells (EC)

Confezionamento

20 mL Clear Glass Screw Cap Vial (855775P-1g)
20 mL Clear Glass Screw Cap Vial (855775P-500mg)
5 mL Amber Glass Screw Cap Vial (855775P-200mg)
5 mL Amber Glass Screw Cap Vial (855775P-25mg)

Note legali

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable


Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 10

1 of 10

17:0 Lyso PC Avanti Research™ - A Croda Brand

Avanti

855676P

17:0 Lyso PC

22:0 Lyso PC 1-behenoyl-2-hydroxy-sn-glycero-3-phosphocholine, powder

Avanti

855779P

22:0 Lyso PC

18:0 Lyso PE 1-Stearoyl-2-Hydroxy-sn-Glycero-3-Phosphoethanolamine, powder

Avanti

856715P

18:0 Lyso PE

18:0 Lyso PA Avanti Research™ - A Croda Brand

Avanti

857128P

18:0 Lyso PA

18:1 Lyso PE Avanti Research™ - A Croda Brand

Avanti

846725P

18:1 Lyso PE

14:0 Lyso PC 1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine, chloroform

Avanti

855575C

14:0 Lyso PC

18:1 Hemi BMP (S,R) sn-(3-oleoyl-2-hydroxy)-glycerol-1-phospho-sn-3′-(1′,2′-dioleoyl)-glycerol (ammonium salt), powder

Avanti

857134P

18:1 Hemi BMP (S,R)

C18(Plasm) LPC 1-O-1′-(Z)-octadecenyl-2-hydroxy-sn-glycero-3-phosphocholine, powder

Avanti

852465P

C18(Plasm) LPC

18:0 PG Avanti Research™ - A Croda Brand

Avanti

840465P

18:0 PG

18:1 Lyso PG 1-oleoyl-2-hydroxy-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), chloroform

Avanti

858125C

18:1 Lyso PG

OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators
Valente AJ, et al.
Free radical biology & medicine, 70, 117-128 (2014)
Optimising DNA binding to carbon nanotubes by non-covalent methods
Vanesa Sanz
Carbon, 49(5), 1775-1781 (2011)
Anthony J Valente et al.
Free radical biology & medicine, 70, 117-128 (2014-02-25)
Oxidized low-density lipoprotein (oxLDL) induces endothelial cell death through the activation of NF-κB and AP-1 pathways. TRAF3IP2 is a redox-sensitive cytoplasmic adapter protein and an upstream regulator of IKK/NF-κB and JNK/AP-1. Here we show that oxLDL-induced death in human primary
Dumindika A Siriwardane et al.
International journal of pharmaceutics, 578, 119077-119077 (2020-01-29)
Identification and quantification of excipient related degradation products in the liposomal formulation is important, as they may impact the safety and efficacy of the drug. Phospholipids are one of the major excipients in liposome drugs composing the lipid bilayer, and
Otto K Kari et al.
Nanoscale, 12(3), 1728-1741 (2020-01-03)
Methodological constraints have limited our ability to study protein corona formation, slowing nanomedicine development and their successful translation into the clinic. We determined hard and soft corona structural properties along with the corresponding proteomic compositions on liposomes in a label-free

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.